According to Vision Research Reports, the pharmaceutical intermediates market size is expected to hit around US$ 53 billion by 2030.
According to Vision Research Reports, the pharmaceutical intermediates market size is expected to hit around US$ 53 billion by 2030.
Rise in prevalence of chronic diseases, focus on research & development by key players and business strategies adopted by key players are the key factors projected to fuel the growth of the global pharmaceutical intermediates market during the forecast period.
The demand for pharmaceutical intermediates majorly depends on the rise in the demand for essential drugs to treat chronic diseases. The growing prevalence of contagious diseases, principally in Southeast Asia, is likely to fuel the demand for APIs in the following years, ultimately propelling the pharmaceutical intermediates market.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38525
Moreover, advancements in technologies such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate identification are increasing the demand for pharmaceutical intermediates for research purposes. Hence, owing to rising production and research exercises in the pharmaceutical industry, the usage of pharmaceutical intermediates is expected to witness a constant growth during the projected period.
Focus on Research & Development to Propel Market
The development of innovative and effective health products for humans has increased in the past few decades. Key players are gearing up to introduce new drugs in the market. The research-based pharmaceutical industry can play a critical role in restoring growth and ensuring future competitiveness in an advancing global economy. The high investment in R&D capabilities and infrastructure by the industries and governments alike is anticipated to create lucrative opportunities in the global pharmaceutical intermediates market. The rising R&D pipeline of India-based companies presents significant in-licensing opportunities for global companies.
Why pharmaceutical intermediates?
Pharmaceutical intermediates are drugs used as raw materials in the production of bulk drugs. Moreover, they are widely used to refer to a material created during the synthesis of an active pharmaceutical ingredient (API) before the processing of becoming an API. Pharmaceutical intermediates are usually formed using high-grade raw materials. These intermediates are widely used in the pharmaceutical and cosmetic industries. The rising demand in these industries is expanding the global pharmaceutical intermediates market. Pharmaceutical intermediates are popularly used for research and development in the pharmaceutical industry. The pharmaceutical intermediates are increasingly being produced using raw materials such as coal tar or petroleum to manufacture pesticides, pharmaceuticals, resins, additives, plasticizers, etc. However, several intermediates can be produced in organic synthesis, and be used in creating various drugs and products.
Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/38525
Report Scope
In terms of product, the global pharmaceutical intermediates market has been bifurcated into bulk drug intermediate and custom intermediate. The bulk drug intermediate segment has been split into chiral intermediate and achiral intermediate.
Based on application, the global pharmaceutical intermediates market has been segregated into cardiology, oncology, endocrinology, infectious diseases, orthopedics, neurology, gastroenterology, dermatology, inflammatory & pain management, ophthalmology, and others. Changes in lifestyle i.e., increase in consumption of tobacco and burden of cancer fuels the growth of the oncology segment.
In terms of end user, the global pharmaceutical intermediates market has been divided into pharmaceutical & biotechnology companies and CROs & CMOs. The fragmented structure of the CRO industry has led to an increase in strategic alliances, acquisitions, joint ventures, and other partnership deals as companies attempt to expand their service offerings and geographical presence.
In terms of region, the North America is expected to account for a significant share of the global pharmaceutical intermediates market during the forecast period. The growth of the pharmaceutical intermediates market in the region can be attributed to rise in access to healthcare and increase in incidence of chronic diseases. According to the World Health Organization, stroke, diabetes mellitus, COPD, and lower respiratory diseases were the top causes of death in 2020.
The market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2030. The increase in the geriatric population is projected to boost the market in the region.
Key Players
The report provides profiles of leading players operating in the global pharmaceutical intermediates market. These include BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, and A. R. Life Sciences Private Limited.
Market Segmentation
By Product
- Bulk Drug Intermediate
-
- Chiral Intermediate
- Achiral Intermediate
-
- Custom Intermediate
By Application
-
- Cardiology
- Oncology
- Endocrinology
- Infectious Diseases
- Orthopedics
- Neurology
- Gastroenterology
- Dermatology
- Inflammatory & Pain Management
- Ophthalmology
- Others
By End User
-
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
By Region
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38525
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333